T-cell correlates of vaccine efficacy after a heterologous simian immunodeficiency virus challenge.
about
Mucosal B Cells Are Associated with Delayed SIV Acquisition in Vaccinated Female but Not Male Rhesus Macaques Following SIVmac251 Rectal ChallengeImmunogenicity of seven new recombinant yellow fever viruses 17D expressing fragments of SIVmac239 Gag, Nef, and Vif in Indian rhesus macaquesGagCM9-specific CD8+ T cells expressing limited public TCR clonotypes do not suppress SIV replication in vivoT cell chemo-vaccination effects after repeated mucosal SHIV exposures and oral pre-exposure prophylaxisVaccine platforms combining circumsporozoite protein and potent immune modulators, rEA or EAT-2, paradoxically result in opposing immune responsesA DNA vaccine encoding multiple HIV CD4 epitopes elicits vigorous polyfunctional, long-lived CD4+ and CD8+ T cell responsesA vaccine encoding conserved promiscuous HIV CD4 epitopes induces broad T cell responses in mice transgenic to multiple common HLA class II moleculesInduction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy.Vaccination with Gag, Vif, and Nef gene fragments affords partial control of viral replication after mucosal challenge with SIVmac239New approaches to design HIV-1 T-cell vaccinesBroad and cross-clade CD4+ T-cell responses elicited by a DNA vaccine encoding highly conserved and promiscuous HIV-1 M-group consensus peptides.DNA/Ad5 vaccination with SIV epitopes induced epitope-specific CD4⁺ T cells, but few subdominant epitope-specific CD8⁺ T cellsCellular immune correlates analysis of an HIV-1 preexposure prophylaxis trial.The majority of freshly sorted simian immunodeficiency virus (SIV)-specific CD8(+) T cells cannot suppress viral replication in SIV-infected macrophages.Reverse vaccinology: developing vaccines in the era of genomicsNew paradigms for HIV/AIDS vaccine development.Interleukin-2 production by polyfunctional HIV-1-specific CD8 T cells is associated with enhanced viral suppressionInitial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replicationGag-specific cellular immunity determines in vitro viral inhibition and in vivo virologic control following simian immunodeficiency virus challenges of vaccinated rhesus monkeys.Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines.Relevance of long-lived CD8(+) T effector memory cells for protective immunity elicited by heterologous prime-boost vaccination.A Recombinant Adenovirus Encoding Multiple HIV-1 Epitopes Induces Stronger CD4(+) T cell Responses than a DNA Vaccine in Mice.DNA Prime-Boost Vaccine Regimen To Increase Breadth, Magnitude, and Cytotoxicity of the Cellular Immune Responses to Subdominant Gag Epitopes of Simian Immunodeficiency Virus and HIV.Dendritic Cell Targeting Effectively Boosts T Cell Responses Elicited by an HIV Multiepitope DNA Vaccine.Complex correlates of protection after vaccination.The role of MHC class I gene products in SIV infection of macaques.Vaccine-induced immune responses against both Gag and Env improve control of simian immunodeficiency virus replication in rectally challenged rhesus macaques.Plasmacytoid dendritic cell and functional HIV Gag p55-specific T cells before treatment interruption can inform set-point plasma HIV viral load after treatment interruption in chronically suppressed HIV-1(+) patients.Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections.
P2860
Q27318151-7BEB9D02-BDFB-4AA5-BFEE-17D58783A542Q27319783-144D4968-9590-4015-AEBD-16FE22B3541AQ27324128-02A10577-79B8-4282-B1DA-0A4115E0D35FQ28477909-70F84FC5-074E-40C1-BCE5-F62386D68DB8Q28740832-DF0A4832-582C-486E-8D58-34AEF85552EEQ28742853-83E17625-0F60-42C9-8266-542F75094234Q28751663-8C63C025-DA3D-4FFC-A076-A603A3FAE52EQ33611645-C5E6F1A3-B838-427E-95E2-B53BF86FBC5EQ33744109-919BA378-8D42-4447-AEA9-3D8078A5F9D1Q34274849-2E8531D5-6A96-49D0-9610-B1ED608118B1Q34428561-87F18816-7E4F-4AE0-85A9-ABD616BDA048Q35269145-2AA7EED7-CF78-472D-8C27-5BDADC0C9EB0Q35845726-4F2EAB96-0B3F-422B-9266-6179C265FC49Q35868086-A8C49D59-BC31-479B-8535-18F5472307CFQ35873940-334D3F90-E267-478D-9A1D-3645C92F2EA5Q36011269-CED3E499-C33E-48E8-984B-99990618AE5AQ36081615-3A47D2BB-D911-4CB8-958E-1518BAD2FE3FQ36086631-DC4072B8-C0A6-4D87-B1C7-83690E928C97Q36246220-D57FB583-FBF1-4B0A-BC6A-742CFAF37563Q36385484-1351B53F-02B3-4198-946C-AD222E73DBF3Q36474557-D421AD44-15D8-461D-B175-51864CBAB6BCQ36956883-D3AB163D-EB1D-4857-BB96-219B2937928DQ37395174-B450579C-C946-4493-95DD-6228BE8A8CA6Q37628515-36D2D72D-6911-4F36-8A51-DE700E537340Q38456515-4A7B310A-715F-4755-B72B-4E4DBA5CCED3Q39427566-2F8CB269-786E-4AFD-9A79-F349309627B4Q40113278-99D80B24-E23D-4920-B3AA-25602862670EQ41482141-96FA489D-4B6A-44B5-99EB-05E7E545C375Q50335281-52F0B252-1392-4FA5-A6EB-896B55794D44
P2860
T-cell correlates of vaccine efficacy after a heterologous simian immunodeficiency virus challenge.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
T-cell correlates of vaccine e ...... unodeficiency virus challenge.
@ast
T-cell correlates of vaccine e ...... unodeficiency virus challenge.
@en
type
label
T-cell correlates of vaccine e ...... unodeficiency virus challenge.
@ast
T-cell correlates of vaccine e ...... unodeficiency virus challenge.
@en
prefLabel
T-cell correlates of vaccine e ...... unodeficiency virus challenge.
@ast
T-cell correlates of vaccine e ...... unodeficiency virus challenge.
@en
P2093
P2860
P50
P356
P1433
P1476
T-cell correlates of vaccine e ...... unodeficiency virus challenge.
@en
P2093
Chanook D Ahn
Jason S Reed
Nancy A Wilson
P2860
P304
P356
10.1128/JVI.02365-09
P577
2010-02-17T00:00:00Z